Evidence map›Paper›PMID 21242673›Full record

Trial reportAmerican journal of nephrology2011

Effects of sodium thiosulfate on vascular calcification in end-stage renal disease: a pilot study of feasibility, safety and efficacy.

Santhosh Jay Mathews, Lisa de las Fuentes, Prashanth Podaralla, Anton Cabellon, Sijie Zheng, Andrew Bierhals, Karen Spence, Eduardo Slatopolsky, Victor G Davila-Roman, James A Delmez

Abstract readClinical Trial
In one paragraph

Trial report in American journal of nephrology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Intravenous sodium thiosulphate for vascular calcification of hemodialysis patients-a systematic review and meta-analysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Pooled it
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. The roles of collagen in chronic kidney disease and vascular calcification.Journal of molecular medicine (Berlin, Germany) · 2021
    Review
  11. Article
  12. Review
  13. Article
  14. Clinical imaging of vascular disease in chronic kidney disease.International urology and nephrology · 2016
    Review
  15. Article
  16. Review
  17. Article
  18. Vascular calcification and renal bone disorders.TheScientificWorldJournal · 2014
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Santhosh Jay MathewsCardiovascular Imaging and Clinical Research Core Laboratory and Cardiovascular Division, Washington University School of Medicine, St. Louis, Mo., USA.
Lisa de las Fuentes
Prashanth Podaralla
Anton Cabellon
Sijie Zheng
Andrew Bierhals
Karen Spence
Eduardo Slatopolsky
Victor G Davila-Roman
James A Delmez
Pediatric Nephrology of Alabama · USCore Laboratories (United States) · USMallinckrodt (United States) · US

Funding

Washington University Center for Kidney Disease ResearchP30DK079333 · NIDDK · WASHINGTON UNIVERSITY · PI HAMMERMAN, MARC RANDALL · 2007 to 2011
$5.1M
NHLBI NIH HHS L30 HL074749NIDDK NIH HHS P30 DK079333NIDDK NIH HHS P30-DK079333
6 · The paper itself

Abstract

BACKGROUND AND

objectivesVascular calcification is a major contributor to morbidity and mortality in hemodialysis. The objective of this pilot study was to determine the feasibility, safety and efficacy of sodium thiosulfate (STS) in the progression of vascular calcification in hemodialysis patients.

methodsChronic hemodialysis patients underwent a battery of cardiovascular tests. Those with coronary artery calcium (Agatston scores >50) received intravenous STS after each dialysis for 5 months (n = 22) and the tests were repeated. Changes in MDCT-determined calcification were assessed as the mean annualized rate of change in 3 vascular beds (coronary, thoracic and carotid arteries) and in L1-L2 vertebral bone density.

resultsAlthough individual analyses showed coronary artery calcification progression in 14/22 subjects, there was no progression in the mean annualized rate of change of vascular calcification in the entire group. The L1-L2 vertebral bone density showed no changes. There were no correlations between rates of progression of vascular calcification and phosphorus, fetuin or C-reactive protein levels. Changes in coronary artery calcification scores correlated with those of the thoracic aorta.

conclusionSTS treatment is feasible, appears safe and may decrease the rate of progression of vascular calcification in hemodialysis patients. A large, randomized, controlled trial is warranted.

Indexed as

Agedalpha-FetoproteinsAorta, ThoracicBone DensityCarotid ArteriesC-Reactive ProteinEchocardiographyFemaleHumansKidney Failure, ChronicMaleMiddle AgedPhosphorusPilot ProjectsRenal DialysisThiosulfatesalpha-FetoproteinsC-Reactive ProteinPhosphorussodium thiosulfateThiosulfates

Identifiers

PMID21242673
PMCPMC3064860
OpenAlexW2036616394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.